Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article
March 2011 Q4 2010 Conference Call - Listen from min 34:00 to 44:00 -> Link
Suffice to say Management has NOT been able to move the needle on Zevalin sales for the LAST 2 YEARS. We hear the same/similar pitch to Investors today from Raj that you heard 2 years ago. The sales still is around $30m in 2012.